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ABSTRACT 
 
Background – It is unclear whether the risk of bleeding from brain arteriovenous 
malformations (BAVMs) is higher during pregnancy, delivery or puerperium. We 
compared occurrence of BAVM hemorrhage in women during this period with 
occurrence of hemorrhage outside this period during their fertile years.  
Methods – We included all women with ruptured BAVMs (16-41 years) from a 
retrospective database of patients with BAVMs in four Dutch university hospitals 
(n=95) and from the population-based Scottish Audit of Intracranial Vascular 
Malformations (n=44). We estimated the relative rate of BAVM rupture (before any 
treatment) during exposed time (pregnancy, delivery, puerperium) versus  non-
exposed time during fertile years, using the case-crossover design as primary 
analysis, and the self-controlled case-series design as secondary analysis. 
Results – In 17 of 95 Dutch women and in 3 of 44 Scottish women, hemorrhages 
occurred while pregnant; none occurred during delivery or puerperium. In Dutch 
women, the relative rate of BAVM rupture during pregnancy, delivery, or puerperium 
was 6.8 (95% confidence interval [CI] 3.6-13) according to the case-crossover 
method and 7.1 (95%CI 3.4-13) using the self-controlled case-series method. In 
Scottish women, the relative rate was 1.3 (95%CI 0.39-4.1) using the case-crossover 
method and 1.7 (95%CI 0.0-4.4) according to the self-controlled case-series method. 
Because of limited overlap of CIs we refrained from pooling the cohorts. 
Conclusions – Case-crossover and self-controlled case series analyses reveal an 
increase in relative rate of brain AVM rupture during pregnancy in the Dutch cohort 
but not in the Scottish cohort. Since point estimates varied between both cohorts and 
numbers are relatively small, the clinical implications of our findings are uncertain. 
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Brain arteriovenous malformations (BAVMs) are abnormal connections between 
arteries and veins leading to arteriovenous shunting with an intervening network of 
vessels – the so-called nidus – and without a true capillary bed.(1,2) The most 
frequent presentation of BAVMs is intracranial hemorrhage, which has a peak 
incidence in the third and fourth decade.(3) Various case-reports and case-series of 
patients with BAVMs have reported the occurrence of hemorrhage during 
pregnancy.(4-7) One study on natural history reported that one in four women aged 
between 20 and 29 years, presenting with hemorrhage, were pregnant.(7) Some 
studies have suggested that women have an increased risk of hemorrhage during 
pregnancy,(8-10) whereas another study did not.(11) 
Investigating the effect of transient exposures such as pregnancy is methodologically 
challenging. Most previous studies compared hemorrhages rates during pregnant, 
and non-pregnant follow-up,(9-11) often in selected patient groups such as women 
referred for radiosurgery.(10,11) In the past, incorrect interpretation of retrospective 
data in one study has led to recommendations to sterilize women with BAVMs.(8,11)  
The effect of transient exposures on acute events can be studied with self-controlled 
methods, which use patients as their own controls in order to ascertain whether there 
is an association between a transient exposure and the acute event. Thus, 
confounding by variation in patients’ characteristics can be avoided.(12-14) By 
means of two different self-controlled methods, we investigated in women with a 
ruptured BAVM whether the relative chance of rupture is higher during pregnancy, 
delivery, and puerperium than outside this period. 
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METHODS 
 
We estimated the relative rate of BAVM hemorrhage during pregnancy, delivery, and 
puerperium using a case-crossover design (Supplementary Figure I) as primary 
analysis, and according to the self-controlled case-series method (Supplementary 
Figure II) as secondary analysis.(12-14) Only the first BAVM hemorrhage during 
untreated follow-up was used (Supplementary Figures I and II). In both analyses 
we assumed a nine-month period (from the 7th week after conception through the 6th 
week after delivery) for the time at risk during pregnancy, delivery, and puerperium. 
The first six weeks of pregnancy were excluded because the hemodynamic changes 
in relation to pregnancy are less prominent during this time. Only the first BAVM 
hemorrhage during untreated follow-up was used in both analyses (Supplementary 
Figures I and II). 
PATIENTS 
We included all women with BAVM hemorrhage at fertile age (i.e. from 16 years up to 
and including 41 years), who were seen in one of four Dutch university hospitals 
(VUMC Amsterdam, AMC Amsterdam, Leiden UMC, and UMC Utrecht; inclusion 
period 1990-2006), or who were included in the population-based Scottish Audit of 
Intracranial Vascular Malformations study (SAIVMs; inclusion periods 1999-2003 and 
2006-2010). The women in the Dutch hospitals were retrospectively identified 
through multiple, overlapping registries in each hospital to ensure that no patients 
were missed: stroke registries, diagnosis registration systems, pathology registries, 
operation registries, registries of embolized and radiosurgically treated patients, and 
neurovascular meetings. The SAIVMs is an on-going National Health Service clinical 
audit of adults who were aged 16 years or older and were resident in Scotland when 
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first diagnosed with any type of intracranial vascular malformation. The Scottish 
Intracranial Vascular Malformations Study (SIVMS) is a prospective, population-
based cohort study in which anonymous data extracts from SAIVMs are used. 
Patients were identified through multiple overlapping sources of case ascertainment, 
which included a Scotland-wide collaborative network of neurologists, 
neurosurgeons, stroke physicians, radiologists, and pathologists, and central 
registers of hospital discharge records and death certificates.(15) 
The fertile period was defined from 16 years up to and including 41 years because in 
the general population 99% of pregnancies occur in women in this age range 
(Statistics Netherlands, www.statline.cbs.nl). The diagnosis of BAVM was confirmed 
with radiological or pathological examination. Patients who were diagnosed with 
hereditary hemorrhagic telangiectasias were excluded. BAVM hemorrhage was 
defined as a symptomatic clinical event, with signs of intracranial blood on brain 
imaging performed at the time of symptoms, lumbar puncture, or on post-mortem 
examination referable to the BAVM or an associated, flow-related aneurysm. All 
hemorrhages were classified as having occurred either during pregnancy, delivery, or 
puerperium, or outside this period. 
In patients with a hemorrhage during pregnancy, delivery, or puerperium, we 
retrieved information on maternal age, gestational age at the time of hemorrhage, 
mode of delivery, location and treatment of the BAVM, and maternal (according to the 
Glasgow Outcome Scale(16)) and fetal outcome. 
Maternity Data 
For women in the Dutch cohort, we used information regarding live-born children that 
was given by patients who participated in a survey to investigate familial occurrence 
of BAVMs,(17) and information retrieved from the medical files.  
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For women in the Scottish cohort, obstetric episodes were obtained from the 
maternity inpatient, and day-case discharges data set by the Information Services 
Division (ISD) in the Scottish Morbidity Records (SMR02). The ISD has consistently 
achieved a national coverage of 98% of all births (www.isdscotland.org/Health-
Topics/Maternity-and-Births/Births/). The SMR02 maternity data were cross-checked 
with any information about previous pregnancies in the case records of the women. If 
a patient, who met the inclusion criteria, did not link with the SMR02 dataset her case 
records were searched for references to any children or previous pregnancies. In 
most cases, these women had never been pregnant. For the women who did not link 
with the SMR02 dataset, and whose case records suggested existing children, the 
patient or her GP was contacted and asked to provide the delivery dates and 
gestations of her children.  
In both Dutch and Scottish women abortions and miscarriages were not taken into 
account. 
Statistical Analysis 
First, we estimated the relative hemorrhage rates during pregnancy, delivery, or 
puerperium, and during non-exposed time, restricting the duration of follow-up to the 
time until the first hemorrhage, for the total cohort and the Dutch and Scottish cohorts 
separately. Subsequently, the relative rate of BAVM hemorrhage during pregnancy, 
delivery, and puerperium was estimated using the case-crossover design as primary 
analysis, and the self-controlled case-series method as secondary analysis.(12-14) 
We planned to analyze the Dutch and Scottish cohorts separately, and subsequently 
combined. 
In the case-crossover analysis (Supplementary Figure I), we expressed the time at 
risk of a woman until occurrence of her first hemorrhage during her fertile years in “9-
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months’ periods” by multiplying the number of years by 12/9 yielding relative rates 
with 95% confidence intervals (CIs). Analyses were performed with SPSS (version 
20). 
In the self-controlled case-series analysis (Supplementary Figure II), we studied the 
first hemorrhage because hemorrhage may affect subsequent exposure (e.g. a 
woman may die after hemorrhage or may be advised against pregnancy). We used 
the extension to the self-controlled case-series method for censored, perturbed or 
curtailed post-event exposures to obtain unbiased relative rate estimates.(14) 
Analyses were performed using STATA (Version 8.1). CIs were estimated using 
bootstrapping. 
Review of the literature 
We searched PubMed for case-series and systematic reviews reporting on women 
with BAVMs and their hemorrhage risk during pregnancy, delivery, and puerperium 
published in English on September 1st, 2016, with the search terms (intracranial 
arteriovenous malformations OR brain arteriovenous malformations) AND intracranial 
hemorrhage AND pregnancy.  
Ethical approval 
The Dutch study was approved by the institutional ethical committee of the University 
Medical Center Utrecht.(17) The Multicenter Research Ethics Committee for Scotland 
(MREC/98/0/48) and the Fife and Forth Valley Research Ethics Committee 
(08/S0501/76) approved the under taking of observational studies (to which an opt-
out consent policy applied) and postal questionnaire studies (which required opt-in 
consent).
Hemorrhage Risk of Brain AVMs during Pregnancy 8 
 
  
RESULTS 
 
In 95 (28%) of 340 women in the Dutch and in 44 (22%) of 202 women in the Scottish 
cohort, hemorrhage occurred during their fertile lives (Table 1).  
With respect to case-ascertainment in the Scottish cohort, three patients were 
reported by ISD only and not by one of the Scottish neuroscience centers. One of 
these three women experienced BAVM hemorrhage during her pregnancy (Table 2).  
On average, women in the Dutch cohort were slightly older than women in the 
Scottish cohort (observed difference 3.0 years, 95%CI 0.62-5.4) at the time they gave 
birth to their first child. The proportion of lobar BAVMs was higher in the Scottish 
cohort (observed difference 21%, 95%CI 4.6-38).  
Dutch cohort 
Seventeen women experienced BAVM hemorrhage during 56 years at risk (relative 
hemorrhage rate 30%/year, 95%CI 18-49%), and in 78 women BAVM rupture 
occurred during 1,231 non-pregnant person years (relative hemorrhage rate 6.3 
%/year, 95%CI 5.0-7.9%). The case-crossover method yielded a relative rate during 
pregnancy, delivery, or puerperium of 6.8 (95%CI, 3.6-13), and the self-controlled 
case-series of 7.1 (95%CI, 3.4-13).  
Scottish cohort 
Three women experienced a hemorrhage during a total of 35 years at risk (relative 
hemorrhage rate 8.6%/year, 95%CI 1.8-25%), and 41 hemorrhages occurred during 
597 non-pregnant person years (relative hemorrhage rate 6.9%/year, 95%CI 4.9-
9.3%). The case-crossover method yielded a relative rate during pregnancy, delivery, 
or puerperium of 1.3 (95%CI, 0.39-4.1), and the self-controlled case-series a relative 
rate of 1.7 (95%CI, 0.0-4.4).  
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Combined cohort  
Given the limited overlap of the CIs of the point estimates, we refrained from pooling 
both cohorts.  
Review of the literature 
We identified five case-series(8-11,18) and two systematic reviews (Table 3).(4,19) 
Two narrative reviews were excluded.(20,21) The most recent case-series – using a 
self-controlled method in large hospital-based, retrospective Chinese cohort – 
showed a decreased hemorrhage risk associated with pregnancy, delivery, and 
puerperium.(19) Another retrospective study concluded that the hemorrhage risk 
during pregnancy was not increased,(11) whereas two studies showed an increased 
risk of BAVM hemorrhage during pregnancy(9) or during the second trimester 
only.(10)  
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DISCUSSION 
 
In the Dutch hospital cohort of women with a ruptured BAVM the relative rupture rate 
was approximately seven times higher during pregnancy, delivery, and puerperium 
than outside this period. The analyses in the smaller population-based Scottish 
cohort did not confirm this increased risk. Limited overlap of the CIs of the point 
estimates hampered the pooled analysis. 
The observed difference in hemorrhage risk during pregnancy, delivery and 
puerperium between the Dutch and Scottish cohorts may have been due to chance, 
especially given the sample sizes. Still, referral bias may have played a role. One 
would think that a woman with BAVM hemorrhage is more likely to get referred to a 
neuroscience center if she is pregnant. Yet, one Scottish woman who experienced a 
BAVM hemorrhage during pregnancy was only reported to the researchers by the 
ISD but not by one of the collaborating neuroscience centers. In the Netherlands, we 
would expect that all young women with BAVM hemorrhage are referred to a 
neurosurgical center unless they have died in a local hospital. Geographic or ethnic 
differences are unlikely to explain the disparate risk during pregnancy, delivery and 
puerperium as both in The Netherlands and Scotland, the large majority of the 
women were Caucasian.  Moreover, hemorrhage rates outside pregnancy were 
similar in both cohorts (6.3%/year vs. 6.9%/year), which makes it also unlikely that 
the higher proportion of women with lobar BAVMs included in the Scottish cohort 
explains the observed difference in hemorrhage risk during pregnancy.  
A recent Chinese hospital-based study showed a decreased hemorrhage risk during 
pregnancy using the case-crossover method.(18) In this study, the relative 
hemorrhage rate during pregnancy, delivery and puerperium (2.7, 12 
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hemorrhages/452 pregnancies; Supplementary Figure III) was remarkably low in 
comparison to the Dutch (18, 17 hemorrhages/95 pregnancies) and to the Scottish 
(6.8, 3 hemorrhages/44 pregnancies) cohort. The relative hemorrhage rate outside 
pregnancy was also lower (4.1%/year) in the Chinese study than in the Dutch 
(6.3%/year) and Scottish (6.9%/year) cohorts. The Chinese women were enrolled 
over a large time frame between 1960 and 2010, and diagnosis of both hemorrhage 
and BAVM is likely to have been less accurate in the earlier decades. Also, the fact 
that the authors included 54 patients with previous hemorrhage or BAVM treatment 
may have influenced their hemorrhage risk as well as the decision to become 
pregnant in some women, and therefore biased their results.(18) Another study, 
which analyzed the effect of pregnancy using Cox proportional hazards regression 
modelling with pregnancy as time-dependent co-variable, yielded an almost eight 
times increased risk of BAVM hemorrhage during pregnancy.(9) This is comparable 
to the results found in the Dutch cohort. 
An important strength of our study is that we used two self-controlled methods(12-14) 
which yielded similar results. We added the self-controlled case-series as a 
secondary analysis because of increased power in comparison to the case-crossover 
design, and the possibility to explicitly control for age- and time-related effects.(14) 
Additionally, we censored women at the time of first hemorrhage because the rupture 
rate increases after a first hemorrhage, and the occurrence of BAVM hemorrhage 
may influence the decision to become pregnant. Moreover, our cohorts were not 
limited to patients who were referred for a certain treatment as in some previous 
studies,(10,11) and we calculated the risk-time from the age of 16 years and not from 
birth.(11)  
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Our study is limited by the small number of included women despite our efforts to 
improve power by combing cohorts. Secondly, case-ascertainment differed between 
the Dutch and Scottish cohorts, which could have contributed to the different results 
during pregnancy. Thirdly, in both cohorts pregnant follow-up may have been 
underestimated by not including abortions and miscarriages. Additionally, 
pregnancies may have been missed by the ISD in Scotland, and the Dutch women 
might not have declared all of their pregnancies when asked. Finally, an important 
limitation of our study with respect to clinical applicability is that with the data we had 
we could calculate relative but no absolute risks of rupture during pregnancy, 
delivery, and puerperium. Moreover, risks for women with unruptured BAVMs cannot 
be deducted from our results. It is important to realize that all women included in our 
study bled, and that in the majority of women hemorrhage was the first presentation 
of their BAVMs (95% Dutch cohort, 98% Scottish cohort; Table 1).  
Although our study cannot provide the final answers, which are needed for clinical 
practice, the results from the Dutch cohort support previous observations that the 
period of pregnancy, delivery and puerperium could increase the risk of BAVM 
rupture in particular with increasing gestational age. Women with a BAVM should be 
informed of the possibility that pregnancy probably increases the risk of BAVM 
hemorrhage, but that the extent to which this occurs is uncertain. Given the annual 
hemorrhage risk of 2.3-3.0% per year,(22,23) a temporary increase during pregnancy 
by ~ 1.5 as found in the Scottish cohort would not infer a considerably larger risk 
whereas an increase by ~ 7 would denote a clinically significant increased 
hemorrhage risk. Whether or not an unruptured BAVM should be treated before 
conception will depend on the characteristics of the BAVM, the individualized 
estimated risk of hemorrhage and treatment, and the informed opinion of the patient. 
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The short-term results of the ARUBA trial - showing a more than three-fold increased 
risk of stroke and death after intervention compared with conservative management 
in patients with unruptured BAVMs – have to be taken into account as well as the 
criticisms with respect to the conduct and outcome of this trial.(24,25) In our view, 
there is no reason to advise discontinuation of pregnancy or sterilization as has been 
done in the past.  
Ideally, the effect of pregnancy on the hemorrhage risk of BAVMs should be 
investigated by the conduct of large multi-center prospective population-based 
studies because these will provide absolute risks during pregnancy for all women 
with BAVMs. Meanwhile, replication of this study design in larger prospectively 
population-cohorts or individual patient data meta-analysis studies can add to the 
current findings. 
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Table 1 Baseline characteristics of 139 women with rupture from BAVMs at fertile 
age 
 Dutch Cohort Scottish Cohort 
Number of patients 95 44 
Initial BAVM presentation 
   Ruptured 
   Unruptured  
Age at first hemorrhage (years) 
   Mean (SD) 
 
90 (95%) 
5 (5.3%) 
 
29 (7.3) 
 
43 (98%) 
1 (2.3%) 
 
30 (7.7) 
Age at birth of first child (years) 
   Mean (SD) 
n = 48 
26 (4.7)   
n = 27 
23 (5.4) 
Number of pregnancies at first 
hemorrhage* 
   0 
   1 
   2 
   3 
   4 
   5 
 
 
51 (54%) 
21 (22%) 
18 (19%) 
4 (4.2%) 
0 
1 (1.1%) 
 
 
19 (43%) 
9 (21%) 
11 (25%) 
5 (11%) 
0 
0 
BAVM Location 
   Lobar 
   Deep 
   Infratentorial 
 
49 (52%) 
27 (28%) 
19 (20%) 
 
32 (73%) 
8 (18%)  
4 (9.1%)  
* Cumulative number of previous pregnancies (including current pregnancy if 
BAVM rupture occurred during pregnancy) prior to the date of first-ever BAVM 
hemorrhage. 
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Table 2 Characteristics of 20 women who experienced BAVM hemorrhage during pregnancy or 
the puerperium 
 Age G/P GA Location BAVM Delivery Treatment BAVM Maternal 
outcome 
Child’s 
outcome 
Dutch cohort 
1 30 
33† 
G1P0 
G2P1 
34 
32 
Thalamus R CS 
CS 
SRS1 
SRS2 
GOS 5 
GOS 5 
Healthy 
Healthy 
2 30 G1P0 27 Frontal R Vaginal Excision GOS 5 IUFD 
3 33 G3P2 41 Parietal R CS  Embolization, RS GOS 5 Healthy 
4 32 G1P0 32  Parietal L CS Excision GOS 4 Healthy 
5 27 G3P2 20 Mesencephalon L CS SRS GOS 4 Healthy 
6 25 G1P0 38 Temporal R CS Excision GOS 5 Healthy 
7 29 G1P0 24 Corpus callosum R CS SRS GOS 5 Healthy 
8 19 G1P0 22 Occipital L CS SRS GOS 5 Healthy 
9 18 G1P0 24 Frontal L CS SRS GOS 5 Healthy 
10 25 G1P0 24 Cerebellum R U SRS GOS 5 Healthy 
11 34 G2P1 12 Multilobar L Vaginal SRS GOS 3 Healthy  
12 24 G1P0 31 Parietal L CS Partial Excision, 
SRS 
GOS 5 Healthy 
13* 33 G2P1 28 Paraventricular R CS SRS GOS 3 Healthy 
14 33 G2P1 33 Basal ganglia R CS None GOS 1 Healthy 
15 35 G1P0 28 Frontal L Vaginal Excision GOS 5 Healthy 
16 22 G1P0 23 Frontal R Vaginal Excision GOS 5 Healthy 
17 24 G1P0 28 Occipital L CS Excision GOS 5 Healthy 
Scottish Cohort 
1 34 G2P1 30 Multilobar R CS Excision GOS 4 Healthy  
2 26 G2P1 22 Multilobar L U Excision GOS 4 IUFD 
3‡ 30 G1P0 7 Insula L CS SRS GOS 4 Healthy 
CS, Caesarean section; G, Gravidity; GA, Gestational age in weeks; GOS, Glasgow Outcome Scale; P, Parity; SRS, 
Stereotactic radiosurgery; U, Unknown; IUFD,  Intrauterine Fetal Death.  
* Excluded from the secondary analysis because the exact date of birth of her first child was unknown which was 
mandatory for the self-controlled case series but not for the case-crossover design.  
† Second hemorrhage is not included in the analyses. 
‡ ISD notification only 
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Table 3 Studies investigating the effect of pregnancy, delivery, and puerperium on the hemorrhage risk of BAVMs 
Author Study 
population  
Methods and analysis Results  Conclusion   
Robinson8 
1974 
Hospital-based  
152 women aged 
< 45 yrs 
diagnosed with 
BAVM (n=33) or 
aneurysm 
(n=113) by DSA 
or at autopsy 
between 1954-
1970 
Retrospective case-
series  
Comparison of 
causative vascular 
lesion in group 1 
(presented < 2 yrs after 
pregnancy, during 
pregnancy, delivery, 
puerperium, or if 
pregnancy followed ≤ 2 
yrs after presentation) 
and group 2 (not 
associated with 
pregnancy). 
 
Follow-up in 146 pts (96%). Group 1 
(67 pts) included 24 pts (36%) with 
BAVMs and 43 (64%) pts with 
aneurysms. 21/24 BAVM pts 
presented with SAH, and 11/21 pts 
bled during pregnancy. 47 
pregnancies occurred in 24 BAVM pts 
resulting in 35 live-born children. 
Group 2 (79 pts) included 9 patients 
(11%) with BAVMs and 70 (89%) with 
aneurysms. Only 1/9 BAVM pts 
presented with SAH. Hemorrhage 
usually occurred between weeks 16-
24, shortly before labor, during 
delivery, or in early puerperium. 
BAVMs were diagnosed in 36% of 
women who presented in association 
with pregnancy, which was 4 times 
higher than the overall numbers 
(9%).  A BAVM pt who never 
becomes pregnant has a relatively 
low risk of SAH; however if a woman 
does become pregnant the chances 
increase to 87%. [Our interpretation: 
if a BAVM is diagnosed in 
association with pregnancy, this will 
be due to hemorrhage in 87% of pts.] 
Dias4 
1990 
Case-reports 
published 
between 1947-
1988 
Review of English 
literature  
Including all reported 
cases of verified 
hemorrhage during 
pregnancy and 
puerperium  
36 pts (mean age 27 yrs) with BAVM 
hemorrhage during pregnancy, of 
whom 2 during labor and delivery. 
26% of women were nulliparous. 
Mean GA 30 weeks. Maternal 
mortality 28%. Fetal mortality 14%. 
BAVMs bleed more frequently 
with advancing GA, possibly due 
to hemodynamic changes of 
pregnancy. Two women with 
BAVMs bled during labor and 
delivery. 
 
Horton11 
1990 
Hospital-based  
451 women with 
a BAVM aged ≥ 
18 yrs diagnosed 
with BAVMs 
referred for 
radiosurgery 
between 1977-
1986 
Retrospective case-
series 
Hospital records 
supplemented by written 
questionnaire.  
Annual hemorrhage 
rates: ratio of number of 
bleeds to pt-yrs during 
pregnant and non-
pregnant FU from birth 
to treatment. 
451 women experienced 459 
hemorrhages during 14,235 pts-yrs, 
i.e. 3.2%/pt-yr. 
540 pregnancies (468.6 pt-yrs) 
occurred in 238 pts. 17 hemorrhages 
occurred during pregnancy, i.e. 
3.6%/pt-yr:  4 (18%) in 1st trim, 7 
(41%) in 2nd trim, 5 (29%) in 3rd trim 
and 2 (12%) in puerperium.  445 
hemorrhages occurred outside 
pregnancy, i.e. 3.2%/pt-yr. 
Risk of non-fatal BAVM during 
pregnancy was 3.5%/pt-yr for pts 
with untreated BAVMs if no 
history of previous hemorrhage.  
 
Forster10 
1993 
Hospital-based  
191 women with 
a BAVM aged 15-
45 years referred 
between 1985 
and 1991 for 
radiosurgery 
 
Retrospective case-
series 
Hospital records 
supplemented by written 
questionnaire. 
Annual hemorrhage 
rates: ratio of number of 
bleeds to pt-yrs during 
pregnant and non-
pregnant FU during 
fertile age.  
229 pregnancies (162 pt-yrs) 
occurred in 116 women. 35 women 
never bled. 207 hemorrhages 
occurred during 2,431 pts-yrs, i.e. 
8.5%/pt-yr. 14 hemorrhages occurred 
during pregnancy (162 pt-yrs), i.e. 
8.6%/pt-yr. 3 (20%) hemorrhages 
occurred in 1st trim, 9 (60%) in 2nd 
trim, 3 (20%) in third trim, but none 
during delivery, CS or in puerperium. 
Hemorrhage rate was unchanged in 
1st (5.3%/yr), 3rd (5.8%/yr) trim, 
increased in 2nd trim (17%/yr). 
Risk of BAVM hemorrhage is 
increased in 2nd trimester of 
pregnancy.  
 
 
Gross9 
2012 
Hospital-based  
58 women with a 
DSA-confirmed 
diagnosis of 
BAVM between 
2002-2010 
Retrospective case-
series 
Annual hemorrhage 
rates: ratio of number of 
bleeds to pt-yrs during 
pregnant and non-
pregnant FU during 
fertile age.  
Cox proportional 
hazards regression 
model with pregnancy 
as time-dependent 
covariate and 
hemorrhage as 
censoring event. 
54 women – with known parturient 
status – experienced a total of 62 
pregnancies. 4 women experienced 5 
hemorrhages while pregnant. Annual 
hemorrhage rate during pregnancy: 
11%/patient year during pregnant 
time. HR for pregnancy was 7.9 (95% 
CI 2.6-24). One hemorrhage occurred 
in 2nd trim, and 4 hemorrhages 
occurred in 3rd trim. 
Elevated risk of hemorrhage from 
BAVMs during pregnancy in 
comparison with non-pregnant 
time. 
 
 
Liu18 
2014 
Hospital-based  
979 women with 
DSA- or PE-
confirmed 
diagnosis of 
BAVM between 
1960-2010. 
Retrospective analysis 
of prospectively 
collected-database 
CCO analysis including 
393 women with BAVM 
hemorrhage at age 
between 18-40 yrs 
Six bleeds occurred in 2nd trim, 5 
hemorrhages in 3rd trim, and one  
in puerperium. 
Relative rate 0.71 (95% CI 0.61-0.82). 
Decreased risk of hemorrhage 
from BAVMs during pregnancy 
and puerperium 
 
 
. 
 
Lx19 Case-reports of 
verified 
hemorrhage 
during pregnancy 
and puerperium 
Review of English 
literature  
 
54 pts with BAVM hemorrhage during 
1st trimester (11%), 2nd trim (44%), 3rd 
trim (41%), and post-partum (4%). 
Maternal mortality 5%. Maternal 
dependence 31%. Fetal mortality 2%. 
Maternal mortality improved over 
time compared to previous 
systematic review. 
 
CCO, Case-crossover; CS,  Caesarean section; GA, Gestational age;  HR, Hazard ratio; PE, Pathological examination; SCCS, self-controlled 
case-series Trim, Trimester 
 
